Two structurally defined A & beta; polymorphs promote different pathological changes in susceptible miceShow others and affiliations
2023 (English)In: EMBO Reports, ISSN 1469-221X, E-ISSN 1469-3178, Vol. 24, no 8, article id e57003Article in journal (Refereed) Published
Abstract [en]
Misfolded A & beta; is involved in the progression of Alzheimers disease (AD). However, the role of its polymorphic variants or conformational strains in AD pathogenesis is not fully understood. Here, we study the seeding properties of two structurally defined synthetic misfolded A & beta; strains (termed 2F and 3F) using in vitro and in vivo assays. We show that 2F and 3F strains differ in their biochemical properties, including resistance to proteolysis, binding to strain-specific dyes, and in vitro seeding. Injection of these strains into a transgenic mouse model produces different pathological features, namely different rates of aggregation, formation of different plaque types, tropism to specific brain regions, differential recruitment of A & beta;(40)/A & beta;(42) peptides, and induction of microglial and astroglial responses. Importantly, the aggregates induced by 2F and 3F are structurally different as determined by ssNMR. Our study analyzes the biological properties of purified A & beta; polymorphs that have been characterized at the atomic resolution level and provides relevant information on the pathological significance of misfolded A & beta; strains.
Place, publisher, year, edition, pages
WILEY , 2023. Vol. 24, no 8, article id e57003
Keywords [en]
amyloid-beta; animal models; prion; protein conformation; strains
National Category
Biochemistry and Molecular Biology
Identifiers
URN: urn:nbn:se:liu:diva-196683DOI: 10.15252/embr.202357003ISI: 001024640700001PubMedID: 37424505OAI: oai:DiVA.org:liu-196683DiVA, id: diva2:1789278
Note
Funding Agencies|Junta de Andaluca Consejera de Economa y Conocimiento of Spain co-financed by Programa Operativo FEDER [P18-RT-2233, Z01-DK029061-14, U42OD11158]; National Disease Research Interchange (NDRI); National Institutes of Health [R56AG061878, RF1AG059321]; Alzheimers Association [AARGD-18-566576]; Health Institute Carlos II (ISCIII) of Spain; European Union; Junta de Andalucia Consejeria de Economia y Conocimiento of Spain; Programa Operativo FEDER 2014-2020 [P18-RT-2233, UMA18-FEDERJA-211]; Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health [Z01-DK029061-14]; NIH [U42OD11158]
2023-08-182023-08-182024-04-04Bibliographically approved